CONMED Corporation (CNMD) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures.
Total Assets Chart for CONMED Corporation
CONMED Corporation (CNMD) total assets for FY2025 were USD 2.3B, a 0.8% change from FY2024. CONMED Corporation's total assets grew from USD 6.4M in 1986 to USD 2.3B in 2025 (36239.8% over 39 years). Total assets compound annual growth rate: 5-year CAGR of 5.8%, 10-year CAGR of 7.6%, 20-year CAGR of 4.8%.
Total Assets (US Dollars)
R&D as % of Revenue
Key Stats
- Market Cap
- $1.40B
- Implied Share Price
- $46.72
- Enterprise Value
- $2.17B
- Revenue (TTM)
- $1.37B
- EBITDA
- $227.46M
- Profit Margin
- 4.12%
- Trailing P/E
- 25.25
- Forward P/E
- 27.17
- Price/Book (MRQ)
- 1.33
- Price/Sales (TTM)
- 1.02
- EV/EBITDA
- 11.56
- EV/Revenue
- 1.59
- Dividend Yield
- —
- Book Value
- $34.73
- Free Cash Flow (FY2025)
- $150.88M
- Free Cash Flow Yield
- 10.78%
Snapshot as of 18th October 2026 — not point-in-time controlled, may lag the live market by a few days.